Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 0 | 966 | 1,528 | 1,225 | 980 |
| Gross Profit | N/A | 966 | 1,528 | 1,225 | 980 |
| Operating Expenses | 11,914 | 11,194 | 11,107 | 11,561 | 10,609 |
| Operating Income | -11,914 | -10,228 | -9,579 | -10,336 | -9,629 |
| Interest Expense | 2,718 | 1,820 | 1,450 | 1,176 | 0 |
| Other Income | 23,618 | -12,973 | -8,818 | -19,649 | 6,082 |
| Pre-tax Income | 8,986 | -25,021 | -19,847 | -31,161 | -3,547 |
| Net Income Continuous | 8,986 | -25,021 | -19,847 | -31,161 | -3,547 |
| Net Income | $8,986 | $-25,021 | $-19,847 | $-31,161 | $-3,547 |
| EPS Basic Total Ops | 0.25 | -0.69 | -0.55 | -0.86 | -0.10 |
| EPS Basic Continuous Ops | 0.25 | -0.69 | -0.55 | -0.86 | -0.10 |
| EPS Diluted Total Ops | 0.25 | -0.69 | -0.48 | -0.86 | -0.17 |
| EPS Diluted Continuous Ops | 0.15 | -0.69 | -0.59 | -0.86 | -0.06 |
| EPS Diluted Before Non-Recurring Items | -0.65 | -0.69 | -0.55 | -0.31 | -0.28 |
| EBITDA(a) | $-11,599 | $-9,911 | $-9,286 | $-10,115 | $-9,401 |